Table 1. Characteristics of Critically Ill COVID-19 Patients.

* Vascular events included prior cerebrovascular accident, coronary artery disease, myocardial infarction, pulmonary embolism, deep vein thrombosis, peripheral arterial disease, HbSC, sickle cell disease

†Obesity was defined as having a BMI ≥30

Characteristic	All Patients (N=102)	African American (N=52)	Hispanic (N=32)	Caucasian (N=7)
Demographics
Median Age – yrs (IQR)	63.22 (53.3-74.3)	63.60 (57.0-76.0)	62.03 (49.8-73.5)	67.86 (64.0-74.0)
Male – no. (%)	55 (53.9)	25 (48.1)	19 (59.4)	5 (71.4)
Medicare/Medicaid – no. (%)	83 (81.4)	41 (78.8)	27 (84.4)	6 (85.7)
Self Pay – no. (%)	3 (2.9)	2 (3.8)	1 (3.1)	0 (0)
Private Insurance – no. (%)	16 (15.7)	9 (17.3)	4 (12.5)	1 (14.3)
Medical History
Charlson Comorbidity Index – avg. (range)	3.38 (0-11)	3.35 (0-9)	3.44 (0-11)	3.57 (0-5)
Body Mass Index – avg.	30.98	32.68	29.87	27.89
Obesity† - no. (%)	44 (43.1)	26 (50.0)	13 (40.6)	2 (28.6)
Diabetes – no. (%)	50 (49.0)	27 (51.9)	16 (50.0)	3 (42.9)
Hypertension – no. (%)	61 (59.8)	30 (57.7)	20 (62.5)	5 (71.4)
Asthma – no. (%)	12 (11.8)	5 (9.6)	2 (6.3)	1 (14.2)
Vascular* – no. (%)	30 (29.4)	16 (30.8)	10 (31.3)	2 (28.6)
Chronic Kidney Disease – no. (%)	11 (10.8)	6 (11.5)	4 (12.5)	0 (0)
Gastroesophageal Reflux Disease (GERD) – no. (%)	10 (9.8)	5 (9.6)	3 (9.4)	2 (28.6)
Human Immunodeficiency Virus – no. (%)	5 (4.9)	4 (7.7)	1 (3.1)	0 (0)
Clinical Characteristics
Hydroxychloroquine + Azithromycin – no. (%)	96 (94.1)	49 (94.2)	29 (90.6)	7 (100)
Vitamin C + Zinc – no. (%)	73 (71.6)	36 (69.2)	24 (75.0)	5 (71.4)
IVIG – no. (%)	8 (7.8)	0 (0)	6 (18.8)	1 (14.3)
Vasopressors – no. (%)	84 (82.4)	42 (80.8)	27 (84.4)	6 (85.7)
Anticoagulation – no. (%)	41 (40.2)	18 (34.6)	17 (53.1)	3 (42.9)
Invasive Mechanical Ventilation – no. (%)	90 (88.2)	44 (84.6)	30 (93.8)	6 (85.7)
Death – no. (%)	61 (59.8)	33 (63.5)	18 (56.3)	4 (57.1)
Discharge from Hospital – no. (%)	10 (9.8)	7 (13.5)	3 (9.4)	0 (0)